Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2003

Study Completion Date

July 31, 2007

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

bevacizumab

DRUG

fluorouracil

DRUG

leucovorin calcium

Trial Locations (33)

10021

New York Weill Cornell Cancer Center at Cornell University, New York

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

20007

Lombardi Cancer Center, Washington D.C.

27710

Duke Comprehensive Cancer Center, Durham

48106

Saint Joseph Mercy Health System, Ann Arbor

55805

St. Mary's/Duluth Clinic Cancer Center, Duluth

57104

Sioux Valley Clinics - Oncology, Sioux Falls

58122

Meritcare Roger Maris Cancer Center, Fargo

59101

CCOP - Montana Cancer Consortium, Billings

60153

Loyola University Medical Center, Maywood

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

73104

University of Oklahoma Health Sciences Center, Oklahoma City

80010

University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora

89106

Southern Nevada Cancer Research Foundation, Las Vegas

90024

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

98101

CCOP - Virginia Mason Research Center, Seattle

98109

Seattle Cancer Care Alliance, Seattle

99519-6604

Providence Alaska Medical Center, Anchorage

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

06520-8028

Yale Comprehensive Cancer Center, New Haven

30342-1701

CCOP - Atlanta Regional, Atlanta

52242-1009

Holden Comprehensive Cancer Center, Iowa City

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

04401

Cancer Care of Maine, Bangor

39216-4505

University of Mississippi Medical Center, Jackson

03756-0002

Norris Cotton Cancer Center, Lebanon

14263-0001

Roswell Park Cancer Institute, Buffalo

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

44106-5065

Ireland Cancer Center, Cleveland

19107-5541

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia

05401

Fletcher Allen Health Care - University Health Center Campus, Burlington

23298-0037

Massey Cancer Center, Richmond

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00066846 - Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy | Biotech Hunter | Biotech Hunter